Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.
Am J Med
; 133(11): 1254-1261, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-638514
ABSTRACT
It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19. We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Cardiovascular Diseases
/
Coronavirus Infections
/
Hospitalists
/
Pandemics
/
Betacoronavirus
/
Internal Medicine
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Am J Med
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS